Table 1.

Monthly estimated and observed new prescriptions of non-vitamin K oral anticoagulants for treatment of non-valvular atrial fibrillation and venous thromboembolism by age group

	Treatment of non-valvular atrial fibrillation
	Overall			<65 years			65–74 years			75 years or older
Month	Estimated	Observed	Δ (95%CI)	Estimated	Observed	Δ	Estimated	Observed	Δ	Estimated	Observed	Δ
March	24 151	14 024	−41.9%	2339	1531	−34.5%	5783	3368	−41.8%	16 085	9125	−43.3%
April	21 427	8811	−58.9%	1894	1052	−44.5%	5100	2147	−57.9%	14 417	5612	−61.1%
May	23 807	13 852	−41.8%	2073	1454	−29.9%	5586	3314	−40.7%	16 172	9084	−43.8%
June	21 382	17 414	−18.6%	1878	1787	−4.8%	5032	3994	−20.6%	14 514	11 633	−19.9%
July	21 288	18 914	−11.2%	1921	1918	−0.2%	5039	4363	−13.4%	14 331	12 633	−11.8%
March–July	112 055	73 015	−34.8%	10 105	7742	−23.4%	26 540	17 186	−35.2%	75 519	48 087	−36.3%
	Treatment of venous thromboembolism
	Overall			<65 years			65–74 years			75 years or older
Month	Estimated	Observed	Δ	Estimated	Observed	Δ	Estimated	Observed	Δ	Estimated	Observed	Δ
March	4701	2756	−41.4%	1461	969	−33.7%	1124	676	−39.9%	2134	1111	−47.9%
April	3938	2732	−30.6%	1234	1163	−5.8%	964	684	−29.1%	1764	885	−49.8%
May	4394	3453	−21.4%	1426	1314	−7.9%	1062	791	−25.5%	1914	1348	−29.6%
June	3875	3753	−3.1%	1290	1298	+0.6%	938	920	−1.9%	1681	1535	−8.7%
July	4265	4065	−4.7%	1426	1479	+3.7%	1008	926	−8.1%	1843	1660	−9.9%
March–July	21 172	16 759	−20.8%	6838	6223	−9.0%	5096	3997	−21.6%	9336	6539	−30.0%

Rows identifying months characterized by the lockdown period are in grey.